Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Erythropoietin Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global erythropoietin drugs market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 6% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Erythropoietin (EPO) is a hormone produced by kidneys to stimulate the production of red blood cells (RBCs). Its deficiency can lead to low hemoglobin levels and various medical conditions. As a result, there is a rise in the demand for EPO drugs, also known as EPO stimulating agents (ESAs), which are produced synthetically using recombinant deoxyribonucleic acid (DNA) technology. They are usually administered via the intramuscular route and released into the bloodstream to stimulate RBC production. At present, they are available in various types with different dosage schedules and modes of delivery. EPO drugs are generally given to patients undergoing chemotherapy, chronic renal failure, and antiviral drug therapy or at high risk for perioperative blood loss from surgical procedures.

Erythropoietin Drugs Market Trends:

Individuals who have anemia due to cancer, prematurity, and chronic kidney disease (CKD) are usually at the risk of low hemoglobin levels. This represents one of the key factors positively influencing the sales of EPO drugs worldwide. In addition, they are used to treat zidovudine among patients with human immunodeficiency virus (HIV) infection. Moreover, the rising need for surgical interventions on account of the growing aging population across the globe is catalyzing the use of EOP drugs to minimize allogeneic blood transfusions after surgical procedures. Furthermore, the escalating demand for minimally invasive (MI) procedures is bolstering the growth of the market. Apart from this, the increasing use of EPO drugs as a novel therapeutic agent in research settings is projected to expand their applications in treating various diseases. These diseases generally include spinal cord injury (SCI), depression, diabetes, acute kidney injury (AKI), recombinant therapy for patients with heart failure, and a neuroprotective agent in ischemic stroke.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global erythropoietin drugs market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on drug class, product type, application and end user.

Breakup by Drug Class:

  • Biologics
  • Biosimilars
     

Breakup by Product Type:

  • Epoetin-alfa
  • Epoetin-beta
  • Darbepoetin-alfa
  • Others
     

Breakup by Application:

  • Hematology
  • Kidney Disorder
  • Cancer
  • Others
     

Breakup by End User:

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc., Biocon Limited, Dr. Reddy’s Laboratories Ltd., F. Hoffmann-La Roche AG, Intas Pharmaceuticals Ltd., Johnson & Johnson, LG Chem Ltd., Pfizer Inc., Sun Pharmaceutical Industries Limited and Teva Pharmaceutical Industries Ltd.

Report Coverages:

Report Features Details
Base Year of the Analysis 2020
    Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Drug Class, Product Type, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Amgen Inc., Biocon Limited, Dr. Reddy’s Laboratories Ltd., F. Hoffmann-La Roche AG, Intas Pharmaceuticals Ltd., Johnson & Johnson, LG Chem Ltd., Pfizer Inc., Sun Pharmaceutical Industries Limited and Teva Pharmaceutical Industries Ltd.
Customization Scope 10% Free Customization
Report Price and Purchase Option                                     Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global erythropoietin drugs market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global erythropoietin drugs market?
  • What are the key regional markets?
  • What is the breakup of the market based on the drug class?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global erythropoietin drugs market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Erythropoietin Drugs Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Drug Class
    6.1    Biologics
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Biosimilars
        6.2.1 Market Trends
        6.2.2 Market Forecast
7    Market Breakup by Product Type
    7.1    Epoetin-alfa
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Epoetin-beta
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Darbepoetin-alfa
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Others
        7.4.1 Market Trends
        7.4.2 Market Forecast
8    Market Breakup by Application
    8.1    Hematology
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Kidney Disorder
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Cancer
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Others
        8.4.1 Market Trends
        8.4.2 Market Forecast
9    Market Breakup by End User
    9.1    Hospitals
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Homecare
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Specialty Clinics
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4    Others
        9.4.1 Market Trends
        9.4.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Amgen Inc.
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis
        15.3.2    Biocon Limited
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
           15.3.2.3 Financials
           15.3.2.4 SWOT Analysis
        15.3.3    Dr. Reddy’s Laboratories Ltd.
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 Financials
           15.3.3.4 SWOT Analysis
        15.3.4    F. Hoffmann-La Roche AG
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
           15.3.4.3 Financials
        15.3.5    Intas Pharmaceuticals Ltd. 
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
        15.3.6    Johnson & Johnson
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
           15.3.6.3 Financials
           15.3.6.4 SWOT Analysis
        15.3.7    LG Chem Ltd.
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
           15.3.7.3 Financials
           15.3.7.4 SWOT Analysis
        15.3.8    Pfizer Inc.
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials
           15.3.8.4 SWOT Analysis
        15.3.9    Sun Pharmaceutical Industries Limited
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    Teva Pharmaceutical Industries Ltd.
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
           15.3.10.3 Financials
           15.3.10.4 SWOT Analysis

List of Figures

Figure 1: Global: Erythropoietin Drugs Market: Major Drivers and Challenges
Figure 2: Global: Erythropoietin Drugs Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Erythropoietin Drugs Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Erythropoietin Drugs Market: Breakup by Drug Class (in %), 2020
Figure 5: Global: Erythropoietin Drugs Market: Breakup by Product Type (in %), 2020
Figure 6: Global: Erythropoietin Drugs Market: Breakup by Application (in %), 2020
Figure 7: Global: Erythropoietin Drugs Market: Breakup by End User (in %), 2020
Figure 8: Global: Erythropoietin Drugs Market: Breakup by Region (in %), 2020
Figure 9: Global: Erythropoietin Drugs (Biologics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Global: Erythropoietin Drugs (Biologics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Erythropoietin Drugs (Biosimilars) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Erythropoietin Drugs (Biosimilars) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Erythropoietin Drugs (Epoetin-alfa) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Erythropoietin Drugs (Epoetin-alfa) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Erythropoietin Drugs (Epoetin-beta) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Erythropoietin Drugs (Epoetin-beta) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Erythropoietin Drugs (Darbepoetin-alfa) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Erythropoietin Drugs (Darbepoetin-alfa) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Global: Erythropoietin Drugs (Other Product Types) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Global: Erythropoietin Drugs (Other Product Types) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Global: Erythropoietin Drugs (Hematology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Global: Erythropoietin Drugs (Hematology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Global: Erythropoietin Drugs (Kidney Disorder) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Global: Erythropoietin Drugs (Kidney Disorder) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Global: Erythropoietin Drugs (Cancer) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Global: Erythropoietin Drugs (Cancer) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Global: Erythropoietin Drugs (Other Applications) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Global: Erythropoietin Drugs (Other Applications) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Global: Erythropoietin Drugs (Hospitals) Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Global: Erythropoietin Drugs (Hospitals) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: Global: Erythropoietin Drugs (Homecare) Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: Global: Erythropoietin Drugs (Homecare) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Global: Erythropoietin Drugs (Specialty Clinics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Global: Erythropoietin Drugs (Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Global: Erythropoietin Drugs (Other End Users) Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Global: Erythropoietin Drugs (Other End Users) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: North America: Erythropoietin Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: North America: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: United States: Erythropoietin Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: United States: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: Canada: Erythropoietin Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: Canada: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: Asia-Pacific: Erythropoietin Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: Asia-Pacific: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: China: Erythropoietin Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: China: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: Japan: Erythropoietin Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: Japan: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: India: Erythropoietin Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: India: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: South Korea: Erythropoietin Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: South Korea: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: Australia: Erythropoietin Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: Australia: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: Indonesia: Erythropoietin Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: Indonesia: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: Others: Erythropoietin Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: Others: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: Europe: Erythropoietin Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: Europe: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: Germany: Erythropoietin Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: Germany: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: France: Erythropoietin Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: France: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 65: United Kingdom: Erythropoietin Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 66: United Kingdom: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: Italy: Erythropoietin Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 68: Italy: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 69: Spain: Erythropoietin Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 70: Spain: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 71: Russia: Erythropoietin Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 72: Russia: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 73: Others: Erythropoietin Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 74: Others: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 75: Latin America: Erythropoietin Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 76: Latin America: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 77: Brazil: Erythropoietin Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 78: Brazil: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 79: Mexico: Erythropoietin Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 80: Mexico: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 81: Others: Erythropoietin Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 82: Others: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 83: Middle East and Africa: Erythropoietin Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 84: Middle East and Africa: Erythropoietin Drugs Market: Breakup by Country (in %), 2020
Figure 85: Middle East and Africa: Erythropoietin Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 86: Global: Erythropoietin Drugs Industry: SWOT Analysis
Figure 87: Global: Erythropoietin Drugs Industry: Value Chain Analysis
Figure 88: Global: Erythropoietin Drugs Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Erythropoietin Drugs Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Erythropoietin Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2021-2026
Table 3: Global: Erythropoietin Drugs Market Forecast: Breakup by Product Type (in Million US$), 2021-2026
Table 4: Global: Erythropoietin Drugs Market Forecast: Breakup by Application (in Million US$), 2021-2026
Table 5: Global: Erythropoietin Drugs Market Forecast: Breakup by End User (in Million US$), 2021-2026
Table 6: Global: Erythropoietin Drugs Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 7: Global: Erythropoietin Drugs Market: Competitive Structure
Table 8: Global: Erythropoietin Drugs Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links